Trifast (TRI) H1 2025 earnings summary

Executive summary

• Recover, Rebuild and Resilience initiatives supported stronger margins and cash generation amid challenging markets.

• Strategy targets profitable growth in automotive, smart infrastructure and medical equipment, supported by operational efficiency and customer-centric growth.

• Progress reported in organisational effectiveness, including distribution standardisation and a One TR model.

• Confidence maintained in achieving mid-term ambitions of at least 10% EBIT margin and 12%-15% ROCE.

Financial highlights

• Revenue fell 1.4% at constant exchange rates to £116.0m and 3.2% at actual exchange rates to £113.9m; low-margin customer and product exits also affected sales.

• Gross margin rose 169bps to 27.4%, its highest since 2020; underlying operating profit increased 9.4% to £7.2m, with margin at 6.2% constant currency and 6% reported.

• Underlying profit before tax rose 29.6% to £5.0m and underlying diluted EPS increased 34.9% to 2.94p; GAAP profit before tax fell 20.8% to £1.6m due to higher one-off items.

• Adjusted net debt fell £12.4m to £15.4m, and leverage improved to 0.9x.

• Underlying profit before tax benefited from gross-margin improvement, lower overheads and interest costs, partly offset by adverse revenue and FX movements.

Outlook and guidance

• FY 2025 results remain on track to meet expectations, with confidence in a good H2 despite variable trading and limited visibility.

• Self-help initiatives are expected to provide further H2 margin benefits; FY 2026 is expected to benefit from £3m of annual cost improvements phased in from the efficiency programme.

• Mid-term ambitions include at least 10% EBIT margin and 12%-15% ROCE, with continued step-by-step improvement expected.

• Target-sector growth pipeline is expected to contribute £20m-£25m; H2 CapEx is expected to exceed H1 to support production, distribution and technology capabilities.